Group One Trading
TENX icon

Group One Trading’s Tenax Therapeutics TENX Stock Holding History

Group One Trading’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Hold
0
– -$2K – 5078
2017
Q1 		– Hold
0
– – – 4461
2016
Q4 		– Hold
0
– – – 4073
2014
Q4 		– Sell
-5
Closed -$601K – 5265
2014
Q3 		$601K Buy
5
+3
+150% +$385K 0.01% 1479
2014
Q2 		$268K Buy
+2
New +$308K ﹤0.01% 2152
2014
Q1 		– Hold
0
– – – 3574

Other funds holding TENX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.61B AUM 19.97% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Group One Trading's TENX Position: Q4 2018 in Review

Group One Trading held its Tenax Therapeutics (TENX) position steady in Q4 2018 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5401.

Group One Trading first reported a position in TENX in Q2 2014 and has held it in 3 quarters since. The position peaked at $587K in Q3 2014. 9 funds tracked by Wall St. Rank hold TENX as of Q4 2018.

  • Group One Trading held 0 shares of Tenax Therapeutics worth $0 as of Q4 2018.
  • Group One Trading left its Tenax Therapeutics share count unchanged in Q4 2018.
  • Tenax Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q4 2018, its #5401 holding.
  • Group One Trading first reported a position in Tenax Therapeutics in Q2 2014 and has held it in 3 quarters since.
  • Group One Trading's Tenax Therapeutics position peaked at $587K in Q3 2014.
  • 9 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q4 2018.

Based on Group One Trading's 13F filing for Q4 2018, filed 6 Feb 2019.